Infusion Therapy Devices

Infusion Therapy Devices Market Outlook

The global Infusion Therapy Devices market is projected to reach approximately USD 20 billion by 2035, growing at a compound annual growth rate (CAGR) of around 7.4% from 2025 to 2035. Factors contributing to this significant growth include the increasing prevalence of chronic diseases, rising aging population, and advancements in infusion technology, which facilitate more efficient and safer drug delivery systems. Furthermore, the increasing acceptance of home healthcare services is pushing the demand for portable infusion devices, thereby driving market expansion. Additionally, the growing trend toward self-administration of drugs by patients at home is revolutionizing the infusion therapy landscape, encouraging manufacturers to innovate and develop more user-friendly and technologically advanced devices.

Growth Factor of the Market

One of the primary growth factors propelling the Infusion Therapy Devices market is the escalating incidence of chronic diseases such as diabetes, cancer, and cardiovascular disorders, which require continuous monitoring and frequent medication administration. This trend is coupled with the aging population that is more susceptible to health issues, thus increasing demand for infusion therapies. Moreover, the rise of outpatient services and homecare setups has significantly augmented the need for safe and efficient infusion devices that can be used outside hospital settings. Another contributing factor is the technological advancements in medical devices, including the integration of smart features like dose error reduction systems and wireless connectivity, which enhance patient safety and improve treatment outcomes. The global push towards value-based healthcare is also encouraging the adoption of infusion therapies that demonstrate superior clinical efficacy while minimizing complications.

Key Highlights of the Market

• The market is witnessing a steady growth rate due to increasing chronic disease prevalence.
• Technological advancements are leading to the development of more effective and user-friendly devices.
• The trend towards home healthcare is significantly impacting market dynamics.
• Regulatory support is facilitating new product approvals and market entries.
• Emerging markets are becoming lucrative due to rising healthcare expenditures.

By Product Type

Intravenous Sets:

Intravenous (IV) sets are critical components in infusion therapy, serving as the primary means for delivering fluids, medications, and nutrients directly into a patient's bloodstream. The market for IV sets is poised for growth owing to their essential role in healthcare settings, particularly in hospitals and clinics. Innovations such as safety IV sets with needle guards and infection control features are being introduced to mitigate risks associated with IV therapy. Furthermore, the increasing emphasis on patient safety and infection prevention is driving demand for advanced IV sets, which, combined with the growing prevalence of surgical procedures, is expected to contribute positively to market growth.

Infusion Pumps:

Infusion pumps are sophisticated devices that allow for the precise administration of medications and fluids, significantly improving treatment accuracy. The infusion pumps segment is anticipated to dominate the market due to their extensive application in various therapeutic areas, including chemotherapy and pain management. The integration of smart technology such as dose calculation systems and alerts for potential errors is further enhancing the efficiency and safety of infusion pumps. Additionally, the rising trend of home healthcare is propelling the demand for portable and easy-to-use infusion pumps that can be utilized in a patient’s home environment, thus expanding their market reach.

Needleless Connectors:

Needleless connectors are increasingly being adopted in infusion therapy as they minimize the risk of needle-stick injuries and enhance patient safety. The growing awareness about the importance of infection control in healthcare settings has led to a surge in the use of needleless systems, which allow for secure and efficient medication administration. This segment is expected to witness robust growth driven by ongoing innovations aimed at improving the design and functionality of these connectors, ensuring a seamless experience for healthcare providers and patients alike while also adhering to the best practices in infection prevention.

IV Cannulas:

IV cannulas are essential in providing access to the vascular system for delivering medications and fluids. The market for IV cannulas is expected to grow significantly as they are widely used in emergency medical care and routine healthcare settings. Innovations such as safety features, including retractable needles and bio-engineered materials to reduce thrombosis, are enhancing the efficacy and safety profiles of IV cannulas. Additionally, the increasing number of surgical procedures and the growing demand for minimally invasive techniques are further contributing to the expansion of this segment within the infusion therapy devices market.

Infusion Catheters:

Infusion catheters serve a crucial role in delivering medications to specific sites in the body and are integral to various therapeutic applications. The infusion catheters market is poised for growth, driven by the rising prevalence of chronic diseases and the need for localized drug delivery methods. The innovation in catheter designs aimed at enhancing patient comfort and reducing complications, such as infections and phlebitis, is also expected to propel the market. The increasing adoption of infusion catheters in outpatient settings and home healthcare will further contribute to the growth of this segment, as patients increasingly seek effective and convenient options for their treatment.

By Application

Chemotherapy:

Chemotherapy remains one of the primary applications of infusion therapy devices, particularly in treating various cancers. The demand for infusion devices in chemotherapy is driven by the increasing incidence of cancer worldwide and the need for precise drug delivery protocols. Infusion devices tailored for chemotherapy applications offer enhanced safety features, including dose tracking and error prevention mechanisms, essential for managing the potent and often toxic nature of chemotherapy drugs. Additionally, advancements in portable infusion technologies are enabling outpatient chemotherapy administration, thereby improving patient comfort and compliance.

Diabetes:

The application of infusion therapy devices in diabetes management is growing, particularly with the rising prevalence of type 1 and type 2 diabetes globally. Insulin pumps and continuous glucose monitoring systems are becoming increasingly popular as they provide diabetic patients with automated insulin delivery, thus improving glycemic control and reducing the risk of complications. The market for these devices is bolstered by advancements in technology, such as smartphone integration, which allows for real-time monitoring and adjustments by healthcare providers. This trend towards personalized and continuous diabetes management is expected to drive further growth in this application segment.

Pain Management:

Pain management is another significant application for infusion therapy devices, utilizing techniques such as patient-controlled analgesia (PCA) to provide effective relief from pain. The increasing recognition of pain as a critical healthcare issue, coupled with the rising incidence of chronic pain conditions, is driving the demand for infusion devices designed specifically for pain management. These devices, which allow patients to self-administer pain medication within preset limits, enhance patient satisfaction and comfort. The growth in outpatient surgeries and the shift toward home-based pain management solutions are further propelling the market for infusion therapy devices in this application.

Clinical Nutrition:

Infusion therapy devices play a vital role in clinical nutrition, particularly for patients unable to meet their nutritional needs through oral intake. The increasing prevalence of conditions requiring parenteral nutrition, such as gastrointestinal disorders and critical illness, is driving demand for infusion devices that facilitate safe and effective delivery of nutrients. The market for these devices is expected to grow as healthcare providers seek to implement nutritional strategies that support patient recovery and overall health. Innovations in intravenous nutrition formulations and delivery systems that ensure optimal nutrient absorption and minimize complications will further enhance the market prospects.

Others:

The "Others" category encompasses various applications of infusion therapy devices, including the administration of antibiotics, sedatives, and other medications in diverse healthcare settings. This segment is experiencing growth due to the increasing number of hospitalizations and the rising complexity of treatments requiring IV medication. The need for flexible and adaptable infusion solutions that can be tailored to various patient needs is driving innovation within this segment. As healthcare providers continue to explore new applications for infusion therapies, the growth potential for this category remains significant.

By Distribution Channel

Hospitals:

Hospitals are the largest distribution channel for infusion therapy devices, accounting for a significant share of the market. The demand within this sector is driven by the high volume of surgeries and critical care procedures that require intravenous therapies. Hospitals benefit from comprehensive patient management systems that include advanced infusion devices with robust monitoring features. Furthermore, the heightened focus on patient safety and infection control within hospital settings is propelling investments in state-of-the-art infusion technologies. As hospitals continue to enhance their infrastructure and services, the demand for reliable and innovative infusion devices is expected to grow.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are becoming increasingly important as a distribution channel for infusion therapy devices, particularly due to the growing trend of outpatient surgeries. ASCs typically offer cost-effective and efficient care, facilitating the use of infusion devices in various surgical procedures. The rising preference for same-day discharge and shorter recovery times is driving the adoption of portable and user-friendly infusion devices in these settings. Additionally, ASCs are increasingly embracing technological advancements to improve patient experiences, which, in turn, boosts the demand for modern infusion solutions tailored to outpatient care.

Specialty Clinics:

Specialty clinics play a vital role in the distribution of infusion therapy devices, particularly in fields such as oncology, pain management, and diabetes care. These clinics often cater to specific patient populations requiring specialized treatments, leading to a heightened demand for targeted infusion devices. The growing emphasis on personalized medicine and tailored treatment approaches is driving innovation within this segment, as clinics seek advanced devices that accommodate unique patient needs. Furthermore, the convenience and accessibility offered by specialty clinics are contributing to the increased utilization of infusion therapies in managing chronic conditions.

Homecare Settings:

The homecare segment is witnessing exponential growth as more patients seek to manage their health conditions from the comfort of their homes. Infusion therapy devices designed for home use, such as portable infusion pumps and pre-filled syringes, are gaining popularity due to their convenience and ease of use. This growth is fueled by the rising prevalence of chronic diseases that require ongoing treatment and the increasing emphasis on patient-centric care models. As healthcare systems shift toward home healthcare solutions, the demand for safe and efficient home infusion devices is expected to rise significantly, providing a substantial opportunity for market players.

Others:

The "Others" category in the distribution channel includes various settings such as pharmacies and outpatient care facilities. While smaller in comparison to hospitals and specialty clinics, this channel is gradually growing as more infusion devices become available for retail purchase. Pharmacies are increasingly offering home infusion services and education on device use, fostering a greater understanding of infusion therapies among patients. As the healthcare landscape evolves, this segment presents opportunities for innovation and expansion, particularly as patients seek convenient and accessible options for their infusion needs.

By Technology

Volumetric Pumps:

Volumetric pumps are one of the most widely used infusion devices due to their ability to deliver precise fluid volumes over a set period. They are commonly used in hospital settings for infusions ranging from simple IV fluids to complex drug therapies. The market for volumetric pumps is expected to grow as they offer enhanced features such as programmable flow rates, alarms for occlusions, and user-friendly interfaces. The increasing focus on patient safety and the need for accurate medication delivery are driving the adoption of volumetric pumps, which are considered a standard in infusion therapy.

Syringe Pumps:

Syringe pumps are designed for accurate and controlled delivery of medications, particularly in applications requiring small volumes of drugs, such as pediatric and neonatal care. The demand for syringe pumps is on the rise due to their precision and ability to minimize medication errors. Innovations such as programmable settings and integrated safety mechanisms are enhancing the functionality of syringe pumps. As healthcare providers seek solutions for complex medication regimens and specialized patient care, the syringe pump segment is expected to witness significant growth, driven by advancements in design and technology aimed at improving patient outcomes.

Elastomeric Pumps:

Elastomeric pumps are disposable, portable infusion devices that deliver medications via a flexible reservoir. These devices are gaining popularity due to their ease of use and the convenience they offer for both patients and healthcare providers. The growing trend towards home healthcare and outpatient treatment is driving the demand for elastomeric pumps, as they provide a simple, safe, and effective method for administering medications at home. The ability to maintain a consistent flow rate and the absence of electrical components make elastomeric pumps a favorable choice, particularly for patients who require long-term medication administration.

Ambulatory Pumps:

Ambulatory pumps are designed for patients requiring infusion therapy while maintaining an active lifestyle. These portable devices enable patients to receive their medications discreetly and comfortably, which is increasingly appealing to those managing chronic conditions. The market for ambulatory pumps is expanding as innovations in design offer more lightweight, user-friendly options with advanced features such as wireless connectivity and mobile app integration. As the healthcare industry continues to prioritize patient-centered care, the demand for ambulatory pumps is expected to grow, providing patients with greater flexibility and autonomy in their treatment.

Implantable Pumps:

Implantable pumps are advanced infusion devices inserted surgically into the body to deliver medications directly to targeted sites. The use of implantable pumps is becoming more prevalent in pain management and specific chronic disease treatments, such as cancer therapy. The market for these devices is driven by the need for long-term drug delivery systems that minimize systemic side effects and improve treatment efficacy. Advances in technology are enhancing the safety and reliability of implantable pumps, making them a viable option for patients requiring continuous medication administration. As the understanding of personalized medicine grows, the adoption of implantable pumps is likely to increase.

By Region

North America is the dominant region in the Infusion Therapy Devices market, accounting for a significant portion of the global share. The region’s growth is primarily attributed to the high prevalence of chronic diseases, significant healthcare expenditures, and the presence of advanced healthcare infrastructure. Moreover, the increasing adoption of infusion devices in outpatient settings, such as homecare and ambulatory surgical centers, is contributing to the expansion of the market. The North American infusion therapy market is expected to grow at a CAGR of over 7% during the forecast period, fueled by continued technological advancements and the rising demand for patient-friendly delivery systems.

Europe is also a key player in the Infusion Therapy Devices market, driven by a robust healthcare system and increasing investments in medical technology. The European market is characterized by a growing focus on patient safety and infection control, which is leading to the adoption of advanced infusion devices with enhanced safety features. Additionally, the rising prevalence of diabetes and cancer in the region is propelling the demand for specialized infusion therapies. The infusion therapy devices market in Europe is expected to witness steady growth, supported by government initiatives aimed at improving healthcare quality and accessibility across member states.

Opportunities

The Infusion Therapy Devices market is poised for remarkable opportunities driven by the increasing demand for home healthcare solutions. With a growing number of patients managing chronic diseases from home, there is a significant need for portable and user-friendly infusion devices that can ensure effective treatment adherence. Manufacturers have the opportunity to innovate and develop advanced devices that integrate smart technologies, such as remote monitoring and mobile applications, allowing caregivers and healthcare providers to track patient progress in real-time. This shift towards homecare not only enhances patient convenience but also improves overall healthcare outcomes, making it a lucrative avenue for market expansion.

Another promising opportunity lies in the emerging markets, where rising healthcare expenditures and improving healthcare infrastructure are creating a favorable environment for the growth of infusion therapy devices. As developing countries continue to expand their healthcare capabilities, there is an increasing recognition of the importance of infusion therapies in managing chronic conditions. Market players can penetrate these markets by offering affordable and reliable infusion solutions, tailored to meet local healthcare needs. Collaborations with local healthcare providers and government initiatives aimed at improving access to treatment can further enhance market presence and drive growth in these regions.

Threats

Despite the promising growth prospects in the Infusion Therapy Devices market, there are several threats that could hinder market expansion. One of the primary concerns is the stringent regulatory environment surrounding medical devices, which can delay product approvals and increase costs for manufacturers. Compliance with evolving regulations and standards often necessitates significant investment in research and development, creating barriers to entry for smaller players in the market. Furthermore, the potential for product recalls due to safety concerns can harm brand reputation and lead to financial losses for manufacturers, detracting from overall market confidence.

Additionally, the competitive landscape is intensifying as new players enter the market and established companies expand their product lines. This increased competition can lead to price wars, which may affect the profitability of manufacturers. Moreover, ongoing advancements in alternative treatment methods and technologies, such as oral medications or injectable drugs that do not require infusion devices, pose a threat to traditional infusion therapies. To sustain their market positions, companies must continuously innovate and enhance the value proposition of their products while addressing the evolving needs of healthcare providers and patients.

Competitor Outlook

• Smiths Medical
• Baxter International Inc.
• Medtronic plc
• BD (Becton, Dickinson and Company)
• Fresenius Kabi AG
• ICU Medical, Inc.
• Terumo Corporation
• Halyard Health, Inc.
• Hospira, Inc. (Acquired by Pfizer)
• Alaris Medical Systems (Becton, Dickinson and Company)
• Vygon S.A.
• CareFusion Corporation (BD)
• Micrel Medical Devices
• Zyno Medical LLC
• Flowonix Medical, Inc.

The competitive landscape of the Infusion Therapy Devices market is characterized by the presence of several established players and emerging companies, all focusing on innovation, quality, and enhanced patient outcomes. Major players are investing heavily in research and development to create advanced infusion technologies that align with the latest healthcare trends and patient preferences. Strategic partnerships, mergers, and acquisitions are common among these companies as they seek to expand their product portfolios and enhance their market reach. Additionally, companies are increasingly focusing on integrating smart technology into their devices, ensuring compliance with safety regulations and improving overall user experience.

Smiths Medical, a leading player in the infusion therapy devices market, is known for its cutting-edge infusion pumps and vascular access devices. The company invests significantly in R&D to develop safe and reliable infusion solutions. In recent years, Smiths Medical has expanded its product offerings to include advanced technology, such as the CADD-Solis ambulatory infusion pump, which features wireless connectivity for real-time monitoring. Baxter International Inc. is another prominent competitor, offering a wide range of infusion systems and accessories. The company has a strong presence in the intravenous solutions market and is committed to expanding its reach in home healthcare by providing innovative products that cater to patient needs.

Medtronic plc, a global leader in medical technology, is also a key player in the infusion therapy devices market. The company provides various infusion solutions, including insulin pumps and pain management systems, aimed at improving patient outcomes. Medtronic has made significant investments in developing integrated solutions that combine devices with software for comprehensive patient management. Similarly, Fresenius Kabi AG focuses on infusion therapy and nutrition, offering a range of products designed to enhance patient care and ensure safety. The company's commitment to quality and innovation positions it well for growth in the competitive infusion therapy market, and its focus on patient-centric solutions continues to drive its success.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Vygon S.A.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic plc
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Smiths Medical
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Zyno Medical LLC
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Fresenius Kabi AG
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 ICU Medical, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Terumo Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Halyard Health, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Flowonix Medical, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Micrel Medical Devices
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Baxter International Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 CareFusion Corporation (BD)
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 BD (Becton, Dickinson and Company)
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Hospira, Inc. (Acquired by Pfizer)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Alaris Medical Systems (Becton, Dickinson and Company)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Infusion Therapy Devices Market, By Technology
    • 6.1.1 Volumetric Pumps
    • 6.1.2 Syringe Pumps
    • 6.1.3 Elastomeric Pumps
    • 6.1.4 Ambulatory Pumps
    • 6.1.5 Implantable Pumps
  • 6.2 Infusion Therapy Devices Market, By Application
    • 6.2.1 Chemotherapy
    • 6.2.2 Diabetes
    • 6.2.3 Pain Management
    • 6.2.4 Clinical Nutrition
    • 6.2.5 Others
  • 6.3 Infusion Therapy Devices Market, By Product Type
    • 6.3.1 Intravenous Sets
    • 6.3.2 Infusion Pumps
    • 6.3.3 Needleless Connectors
    • 6.3.4 IV Cannulas
    • 6.3.5 Infusion Catheters
  • 6.4 Infusion Therapy Devices Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Ambulatory Surgical Centers
    • 6.4.3 Specialty Clinics
    • 6.4.4 Homecare Settings
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Infusion Therapy Devices Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Infusion Therapy Devices market is categorized based on

By Product Type

• Intravenous Sets
• Infusion Pumps
• Needleless Connectors
• IV Cannulas
• Infusion Catheters

By Application

• Chemotherapy
• Diabetes
• Pain Management
• Clinical Nutrition
• Others

By Distribution Channel

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Homecare Settings
• Others

By Technology

• Volumetric Pumps
• Syringe Pumps
• Elastomeric Pumps
• Ambulatory Pumps
• Implantable Pumps

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Smiths Medical
• Baxter International Inc.
• Medtronic plc
• BD (Becton, Dickinson and Company)
• Fresenius Kabi AG
• ICU Medical, Inc.
• Terumo Corporation
• Halyard Health, Inc.
• Hospira, Inc. (Acquired by Pfizer)
• Alaris Medical Systems (Becton, Dickinson and Company)
• Vygon S.A.
• CareFusion Corporation (BD)
• Micrel Medical Devices
• Zyno Medical LLC
• Flowonix Medical, Inc.